文献速递心力衰竭与心肌病血脂与心血管预防

肥厚型心肌病患者高强度运动方案随机试验

High intensity exercise programme in patients with hypertrophic cardiomyopathy: a randomized trial.
PubMed 文献 · Eur Heart J · 2025-01-01

多数获益在6个月时消退,需大规模研究验证长期安全性。

要点

  • HCM患者12周高强度运动方案可行,依从性良好,资源符合国家心脏康复标准
  • 运动组峰值摄氧量增加4.1 mL/kg/min,收缩压降低7.3 mmHg,焦虑抑郁评分改善

核心结论

  • HCM患者高强度运动方案可行,具有心血管和心理获益,且不增加心律失常。
  • 需大规模研究证实结果并评估长期安全性。

研究设计与样本

  • 所有参与者基线和12周评估,运动组在方案结束后6个月再评估。
  • 可行性评估包括招募、依从性和保留率、人员配比、后勤和干预可接受性。

主要发现

  • 67例(84%)完成研究,运动组34例,常规护理组33例;不依从原因包括旅行、工作和家庭事务。
  • 12周时运动组峰值摄氧量增加4.1 mL/kg/min(95%CI 1.1-7.1),无氧阈摄氧量增加2.3 mL/kg/min(95%CI 0.4-4.1)。
  • 运动组收缩压降低7.3 mmHg(95%CI -11.7至-2.8),体重指数降低0.8 kg/m2(95%CI -1.1至-0.4)。
  • 运动组医院焦虑评分改善-3(95%CI -4.3至-1.7),抑郁评分改善-1.7(95%CI -2.9至-0.5)。

临床怎么用

  • HCM患者可考虑在监督下进行高强度运动训练,以改善心肺适能和心血管危险因素。
  • 运动方案可能改善焦虑抑郁症状,但需注意获益在停止训练后可能消退。

局限性

  • 探索性安全性结局,样本量小,需大规模研究证实。
  • 多数运动获益在6个月时消退。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: The feasibility and impact of high intensity exercise programmes in patients with hypertrophic cardiomyopathy (HCM) are unknown. This study was conducted to determine the feasibility of a high intensity exercise programme and explore safety and efficacy outcomes in patients with HCM. METHODS: Participants were randomized to a 12-week supervised exercise programme (n = 40) in addition to usual care, or usual care alone (n = 40). All participants underwent assessment at baseline and 12 weeks. The exercise group was re-evaluated 6 months post-programme. Feasibility was assessed by (i) recruitment, adherence, and retention rates; (ii) staffing ratios; (iii) logistics; and (iv) acceptability of the intervention. The primary exploratory safety outcome was a composite of arrhythmia-related events. Exploratory secondary outcomes included changes in (i) cardiorespiratory fitness; (ii) cardiovascular risk factors; and (iii) quality of life, anxiety, and depression scores. RESULTS: Overall, 67 (84%) participants completed the study (n = 34 and n = 33 in the exercise and usual care groups, respectively). Reasons for non-adherence included travel, work, and family commitments. Resource provision complied with national cardiac rehabilitation standards. There was no difference between groups for the exploratory safety outcome (P = .99). At 12 weeks, the exercise group had a greater increase in peak oxygen consumption (VO2) [+4.1 mL/kg/min, 95% confidence interval (CI) 1.1, 7.1] and VO2 at anaerobic threshold (+2.3 mL/kg/min, 95% CI 0.4, 4.1), lower systolic blood pressure (-7.3 mmHg, 95% CI -11.7, -2.8) and body mass index (-0.8 kg/m2, 95% CI -1.1, -0.4), and greater improvement in hospital anxiety (-3, 95% CI -4.3, -1.7) and depression (-1.7, 95% CI -2.9, -0.5) scores, compared to the usual care group. Most exercise gains dissipated at 6 months. CONCLUSIONS: A high intensity exercise programme is feasible in patients with HCM, with apparent cardiovascular and psychological benefits, and no increase in arrhythmias. A large-scale study is required to substantiate findings and assess long-term safety of high intensity exercise in HCM.

来源:Eur Heart J,查看原文。版权归原作者所有。

引用

  1. Basu J, Nikoletou D, Miles C, et al. High intensity exercise programme in patients with hypertrophic cardiomyopathy: a randomized trial. Eur Heart J. 2025. PMID: 40037382. doi:10.1093/eurheartj/ehae919

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。